Sort
82,697 grants matching “vaccine development”
DNA Vaccine Delivery System for Biodefense with dengue
$1,226,619Alan D King · Cyto Pulse Sciences, Inc. · R44 · FY2006 · AI
Seattle-Lausanne Clinical Trials Unit
$1,226,577Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Medical Scientist Training Program
$1,226,546Christopher S. Williams · Vanderbilt University · T32 · FY2016 · GM
An immune-based approach for HIV eradication
$1,226,363Juan Lama · Retrovirox, Inc. · R44 · FY2016 · AI
COVID-19 testing and vaccination social network diffusion for diverse criminal legal involved communities
$1,226,130John Schneider · University Of Chicago · U01 · FY2022 · MD
Bronx-Lebanon Hospital Clinical Trials Unit
$1,226,127Murli U Purswani · Bronxcare Health System · U01 · FY2007 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,226,023Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Computational Models of Adaptive Immunity to Influenza
$1,225,986Sarah Cobey · University Of Chicago · U01 · FY2025 · AI
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$1,225,983Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2007 · AI
Discovery of new anti-bacteremia vaccines for anthrax
$1,225,780Macrogenics, Inc. · U01 · FY2004 · AI
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,225,767Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2023 · CA
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2023 · HD
Clinical evaluation of SARS-CoV-2 subunit vaccine in a Phase I human clinical study
$1,225,641Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2020 · AI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,614Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2020 · HD
Specific Pathogen Free Baboon Research Resource (SPFBRR)
$1,225,576Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2020 · OD
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,225,410Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2017 · CA
Project 1: Rational design of targeted vaccines to induce HIV V2-apex bnAb responses
$1,225,307Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI
Core C: Viral Evolution
$1,225,278Jesse D Bloom · University Of Washington · P01 · FY2022 · AI
Primate Core
$1,225,263Roger A Van Andel · University Of New Mexico · P01 · FY2006 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,225,136University Of Alabama At Birmingham · U01 · FY2002 · AI
Vanderbilt HIV Clinical Trials Unit
$1,224,853David W Haas · Vanderbilt University Medical Center · UM1 · FY2016 · AI
Structural Biology Of Virus Assembly
$1,224,707Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
$1,224,706Beth Diane Kirkpatrick · University Of Vermont & St Agric College · U01 · FY2024 · AI
Immunity to Pulmonary Infections
$1,224,662Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI